Search for: "MAJOR PHARMACEUTICALS" Results 481 - 500 of 4,373
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Dec 2021, 1:32 pm by luiza
Hamsa Mahendranathan joined the firm in 2015 and has worked for many years across practices, including major whistleblower and antitrust litigations, several SEC whistleblower cases, pro bono work, and more. [read post]
5 Dec 2021, 4:26 pm by Eugene Volokh
[The Ninth Circuit held a week ago that the school district had to give religious exemptions so long as it categorically exempted pregnant students; now that the district has repealed the pregnancy exemption, no religious exemptions are required.] [read post]
30 Nov 2021, 12:48 pm by Patrick A. Malone
The regular folks who make up juries may give more heed than judges and justices do to the how and why of patients’ push for justice in the civil system, as has been shown in yet another bellwether decision involving major drug store chains and claims they contributed to the nation’s worsening opioid abuse and drug overdose crisis. [read post]
30 Nov 2021, 9:36 am by Dennis Crouch
On appeal, the majority classified the disclosure of 480 mg/day as a “sole reference . . [read post]
30 Nov 2021, 1:29 am by Lebowitz & Mzhen
At both local pharmacies and corporate headquarters, the plaintiffs argued, oversight requirements in all three major retailers failed to take red flags into account, which led to the pharmaceutical companies contributing to the creation and sustained nature of the opioid public health crisis. [read post]
29 Nov 2021, 1:55 pm by Tom Lamb
In the new pooled analysis, the incidence of major adverse cardiovascular events (MACE) for Olumiant was 0.51 per 100 patient-years of exposure, which Lilly said falls within the range in the general rheumatoid arthritis population as described in epidemiological studies. [read post]
24 Nov 2021, 10:41 am by Amber Walsh
Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries. [read post]
23 Nov 2021, 9:03 pm by Alana Sheppard
A vast majority of drugs approved by FDA fall into this “me-too” category. [read post]
23 Nov 2021, 10:09 am by Patricia Hughes
The past and current restrictions have been different: they have contemporaneously affected more people (that is, most of us across the country in different ways — we learned “we aren’t in this together”); and this time many more of the majority population, so perhaps they seem different and more offensive to the rule of law from the Declaration’s authors’ perspective. [read post]
23 Nov 2021, 1:35 am by Christian Romero
Episode 102 of EFF’s How to Fix the Internet The open source movement focuses on collaboration and empowerment of users. [read post]
22 Nov 2021, 12:17 pm by Holly Buckley
Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries. [read post]
19 Nov 2021, 10:46 am by Rebecca Tushnet
Neurelis argued that the exemption to the anti-SLAPP law was specifically focused on overturning DuPont Merck Pharmaceutical Co. v. [read post]
14 Nov 2021, 6:40 am by Bob Kraft
The Impact of Legal Medical Issues on Healthcare Costs A medical malpractice lawsuit can put a major dent in your budget. [read post]
12 Nov 2021, 11:55 am by Joe Consumer
But now a major legal theory, one with real promise for holding accountable the pharmaceutical industry for this crisis, may be dead. [read post]
12 Nov 2021, 3:00 am by Jim Sedor
A 2019 report by the Justice Department inspector general found major problems with the accuracy of Danchenko’s information. [read post]
11 Nov 2021, 4:41 pm by Bona Law PC
The SAMR has used anticompetitive intent to override this defense in the high-profile RPM enforcement case against Yangtze River pharmaceutical company9. [read post]
8 Nov 2021, 6:42 am by John Jascob
In that matter, an employee at a pharmaceutical company called Medivation traded on inside information that the company would be acquired by Pfizer. [read post]
4 Nov 2021, 7:03 pm by Edward T. Kang and Ryan T. Kirk
This trend is particularly evident in the pharmaceutical sector, where violations of the FCA have forced corporate behemoths like GlaxoSmithKline and Pfizer into billion-dollar settlements. [read post]
The court said that the generic companies’ manufacturing or selling of these tablets may amount to infringement of a patent owned by major pharmaceutical company Novartis AG. [read post]